Literature DB >> 15111823

Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.

Claudio Ungari1, Giovanni Rocchi, Claudio Rinna, Alessandro Agrillo, Alessandro Lattanzi, Mario Pagnoni.   

Abstract

Oncogenic osteomalacia is an uncommon syndrome characterized by bone pain, proximal muscle weakness, hypophosphatemia, hyperphosphaturia, and a low plasma concentration of 1,25-dihydroxy-vitamin D. The disease affects both sexes at around 40 years of age, although it can sometimes affect children and adolescents. Generally, the syndrome is associated with a tumor, usually benign, of mesenchymal origin and is resolved after removal of the tumor; this syndrome can sometimes be associated with malignant tumors. These tumors seem to be histologically heterogeneous and are generally localized in soft tissues and bone. In this article, a case of oncogenic osteomalacia associated with a hypophosphaturic mesenchymal tumor of the ethmoid is reported in a 24-year-old man. After surgical and radical removal of the tumor, the patient noted a decrease in the clinical symptoms and signs.

Entities:  

Mesh:

Year:  2004        PMID: 15111823     DOI: 10.1097/00001665-200405000-00036

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  14 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

2.  Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.

Authors:  Pallavi Suryawanshi; Manish Agarwal; Rahul Dhake; Saral Desai; Bharat Rekhi; Kishor B Reddy; Nirmala Ajit Jambhekar
Journal:  Skeletal Radiol       Date:  2011-05-01       Impact factor: 2.199

Review 3.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

4.  Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.

Authors:  Regina S Bower; Wilson P Daugherty; Caterina Giannini; Ian F Parney
Journal:  Surg Neurol Int       Date:  2012-12-14

Review 5.  Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

Authors:  Victoria L Woo; Regina Landesberg; Erik A Imel; Steven R Singer; Andrew L Folpe; Michael J Econs; Taeyun Kim; Lara R Harik; Thomas P Jacobs
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-10-14

6.  Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity.

Authors:  Demetri Arnaoutakis; Iman Naseri
Journal:  J Neurol Surg Rep       Date:  2015-08-21

7.  Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review.

Authors:  Nicholas L Deep; Rachel B Cain; Ann E McCullough; Joseph M Hoxworth; Devyani Lal
Journal:  Allergy Rhinol (Providence)       Date:  2014-01

8.  Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience.

Authors:  Avani S Jain; Simon Shelley; Indirani Muthukrishnan; Shilpa Kalal; Jaykanth Amalachandran; Sureshkumar Chandran
Journal:  Indian J Nucl Med       Date:  2016 Jan-Mar

Review 9.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

Review 10.  Phosphaturic mesenchymal tumor and related wound problem.

Authors:  Xian Xiao; Xiaofang Sun; Pengwen Ni; Yao Huang; Ting Xie
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.